These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2320656)

  • 1. Effects of perifornical hypothalamic microinjections of phenylpropanolamine and amphetamine on latency to feed and mash intake in rats.
    Wellman PJ; Cockroft R
    Pharmacol Biochem Behav; 1990 Feb; 35(2):461-4. PubMed ID: 2320656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of paraventricular hypothalamic microinjections of phenylpropanolamine and d-amphetamine on mash intake in rats.
    Wellman PJ; Davies BT
    Brain Res Bull; 1990 Aug; 25(2):335-8. PubMed ID: 2224544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amphetamine and phenylpropanolamine on latency to feed and cumulative liquid diet intake in rats.
    Wellman PJ; Cockroft R
    Pharmacol Biochem Behav; 1989 Jan; 32(1):147-50. PubMed ID: 2734326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol on anorexia induced by l-norephedrine and d-amphetamine in adult rats.
    Wellman PJ
    Pharmacol Biochem Behav; 1990 Feb; 35(2):457-60. PubMed ID: 2320655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of phenylpropanolamine, d-amphetamine and d-norpseudoephedrine on open-field locomotion and food intake in the rat.
    Eisenberg MS; Maher TJ; Silverman HI
    Appetite; 1987 Aug; 9(1):31-7. PubMed ID: 3662492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylpropanolamine decreases food intake in rats made hyperphagic by various stimuli.
    Moya-Huff FA; Maher TJ
    Pharmacol Biochem Behav; 1987 Sep; 28(1):71-4. PubMed ID: 3310024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amphetamine and phenylpropanolamine on food intake in rats with ventromedial hypothalamic or dorsolateral tegmental damage.
    Wellman PJ; Peters RH
    Physiol Behav; 1980 Dec; 25(6):819-27. PubMed ID: 7220624
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
    McMahon LR; Wellman PJ
    Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned taste reactivity in rats after phenylpropanolamine, d-amphetamine or lithium chloride.
    Davies BT; Wellman PJ
    Pharmacol Biochem Behav; 1990 Aug; 36(4):973-7. PubMed ID: 2171001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of oxidative stress in hypothalamic ghrelin-associated appetite control in rats treated with phenylpropanolamine.
    Yu CH; Chu SC; Chen PN; Hsieh YS; Kuo DY
    Genes Brain Behav; 2017 Apr; 16(4):439-448. PubMed ID: 27862969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomers of phenylpropanolamine suppress food intake in hyperphagic rats.
    Eisenberg MS; Maher TJ
    Pharmacol Biochem Behav; 1990 Apr; 35(4):865-9. PubMed ID: 2189144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of receptor sensitivity changes in rat perifornical hypothalamus: a role for dopaminergic receptors in amphetamine anorexic tolerance.
    Bhakthavatsalam P; Kamatchi GL; Ghosh MN
    J Pharmacol Exp Ther; 1987 Jan; 240(1):196-202. PubMed ID: 3468240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the involvement of paraventricular hypothalamic alpha 2-adrenoceptors in phenylpropanolamine anorexia.
    Davies BT; Wellman PJ; Morien A
    Physiol Behav; 1993 Jul; 54(1):121-8. PubMed ID: 8392206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical evaluation of phenylpropanolamine.
    Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1992 May; 42(1):97-100. PubMed ID: 1356275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities between the stimulus properties of phenylpropanolamine and amphetamine.
    Lee F; Stafford I; Hoebel BG
    Psychopharmacology (Berl); 1989; 97(3):410-2. PubMed ID: 2497491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.